Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Rating of "Buy" by Analysts

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has been given an average recommendation of "Buy" by the ten brokerages that are presently covering the firm, Marketbeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $29.40.

A number of equities research analysts have recently weighed in on ASPN shares. TD Cowen lifted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a research report on Tuesday, August 20th. HC Wainwright reiterated a "buy" rating and issued a $30.00 price target on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Benchmark restated a "buy" rating and set a $14.00 price objective on shares of Aspen Aerogels in a research report on Thursday, August 8th. StockNews.com upgraded shares of Aspen Aerogels to a "sell" rating in a research report on Thursday, October 31st. Finally, Roth Mkm restated a "buy" rating and set a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st.

Aspen Aerogels Stock Performance

ASPN stock traded down $1.65 during mid-day trading on Wednesday, hitting $16.86. 6,360,166 shares of the company were exchanged, compared to its average volume of 1,529,981. The business has a 50 day simple moving average of $23.82 and a 200-day simple moving average of $24.71. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The stock has a market capitalization of $1.30 billion, a PE ratio of -1,851.00 and a beta of 2.21. Aspen Aerogels has a 1-year low of $8.76 and a 1-year high of $33.15.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. During the same period in the previous year, the business earned ($0.22) earnings per share. The firm's quarterly revenue was up 144.4% on a year-over-year basis. On average, equities analysts forecast that Aspen Aerogels will post 0.1 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business's stock in a transaction on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company's stock.

Hedge Funds Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently bought and sold shares of ASPN. Point72 Hong Kong Ltd acquired a new position in Aspen Aerogels in the second quarter valued at $84,000. nVerses Capital LLC acquired a new position in Aspen Aerogels in the second quarter valued at $95,000. Quent Capital LLC acquired a new position in Aspen Aerogels in the third quarter valued at $118,000. Point72 DIFC Ltd acquired a new position in Aspen Aerogels in the second quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new position in Aspen Aerogels in the second quarter valued at $145,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.